• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性基底细胞癌在神经纤维瘤病中的治疗应用脉冲染料激光。

Multiple basal cell carcinomas in Gorlin Syndrome treated with pulsed dye laser.

机构信息

Department of Dermatology, University of Rochester Medical Center, Rochester, NY, USA.

出版信息

J Cosmet Laser Ther. 2020 Nov 16;22(6-8):230-231. doi: 10.1080/14764172.2021.1914852. Epub 2021 Apr 14.

DOI:10.1080/14764172.2021.1914852
PMID:33849368
Abstract

This is an observational study demonstrating the effectiveness of pulsed dye laser (PDL) as a treatment of basal cell carcinomas (BCC) in patients with Gorlin Syndrome. Over 200 BCCs localized to the head, neck, trunk, and extremities of a patient suffering from Gorlin Syndrome were successfully treated with PDL without subsequent scarring. PDL is a simple and rapid modality to destroy BCCs arising in patients with Gorlin Syndrome resulting in a preferable cosmetic outcome.

摘要

这是一项观察性研究,证明了脉冲染料激光(PDL)治疗神经纤维瘤病患者基底细胞癌(BCC)的有效性。一名患有神经纤维瘤病的患者,其头部、颈部、躯干和四肢的 200 多个 BCC 成功地接受了 PDL 治疗,且无后续瘢痕形成。PDL 是一种简单快速的方法,可以破坏神经纤维瘤病患者中出现的 BCC,从而获得更好的美容效果。

相似文献

1
Multiple basal cell carcinomas in Gorlin Syndrome treated with pulsed dye laser.多发性基底细胞癌在神经纤维瘤病中的治疗应用脉冲染料激光。
J Cosmet Laser Ther. 2020 Nov 16;22(6-8):230-231. doi: 10.1080/14764172.2021.1914852. Epub 2021 Apr 14.
2
The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas.595纳米脉冲染料激光对浅表性和结节性基底细胞癌的影响。
Lasers Surg Med. 2009 Aug;41(6):417-22. doi: 10.1002/lsm.20787.
3
Single treatment of low-risk basal cell carcinomas with pulsed dye laser-mediated photodynamic therapy (PDL-PDT) compared with photodynamic therapy (PDT): A controlled, investigator-blinded, intra-individual prospective study.低风险基底细胞癌采用脉冲染料激光介导光动力疗法(PDL-PDT)与光动力疗法(PDT)的单治疗比较:一项对照、研究者盲法、个体内前瞻性研究。
Photodiagnosis Photodyn Ther. 2016 Dec;16:60-65. doi: 10.1016/j.pdpdt.2016.08.003. Epub 2016 Aug 8.
4
Combined 585 nm pulsed-dye and 1,064 nm Nd:YAG lasers for the treatment of basal cell carcinoma.联合使用585纳米脉冲染料激光和1064纳米钕:钇铝石榴石激光治疗基底细胞癌。
Lasers Surg Med. 2014 Jan;46(1):1-7. doi: 10.1002/lsm.22201. Epub 2013 Nov 23.
5
Single treatment of non-melanoma skin cancers using a pulsed-dye laser with stacked pulses.使用具有堆叠脉冲的脉冲染料激光单次治疗非黑色素瘤皮肤癌。
Lasers Surg Med. 2012 Aug;44(6):459-67. doi: 10.1002/lsm.22032. Epub 2012 Apr 17.
6
The pulsed dye laser for the treatment of basal cell carcinoma.脉冲染料激光治疗基底细胞癌。
Lasers Med Sci. 2011 Sep;26(5):641-4. doi: 10.1007/s10103-011-0952-8. Epub 2011 Jul 12.
7
Pulsed dye laser as a novel non-surgical treatment for basal cell carcinomas: response and follow up 12-21 months after treatment.脉冲染料激光作为一种治疗基底细胞癌的新型非手术疗法:治疗后12至21个月的反应及随访
Lasers Surg Med. 2011 Feb;43(2):72-8. doi: 10.1002/lsm.21035.
8
Effectiveness of a 595-nm Pulsed Dye Laser for the Treatment of Basal Cell Carcinoma Using One Double-Stacked Pulse Session: A Randomized, Double-Blinded Controlled Trial.595nm 脉冲染料激光单次双堆叠脉冲治疗基底细胞癌的疗效:一项随机、双盲对照临床试验。
Dermatol Surg. 2021 May 1;47(5):630-633. doi: 10.1097/DSS.0000000000002689.
9
Pulsed dye laser in the treatment of basal cell carcinoma: A single session versus two sessions - a randomized controlled trial.脉冲染料激光治疗基底细胞癌:单次治疗与两次治疗的随机对照试验。
Indian J Dermatol Venereol Leprol. 2019 Sep-Oct;85(5):475-480. doi: 10.4103/ijdvl.IJDVL_644_17.
10
Fragile hands: targeting nonmelanoma skin cancer on older hands using 595 nm pulsed dye laser.脆弱的双手:使用 595nm 脉冲染料激光治疗老年手上的非黑素瘤皮肤癌。
Lasers Med Sci. 2024 Apr 17;39(1):101. doi: 10.1007/s10103-024-04047-6.

引用本文的文献

1
Modulation of Hedgehog Signaling for the Treatment of Basal Cell Carcinoma and the Development of Preclinical Models.用于治疗基底细胞癌的刺猬信号通路调节及临床前模型的开发
Biomedicines. 2022 Sep 23;10(10):2376. doi: 10.3390/biomedicines10102376.